Carolyn Drake

Doctors may be halting use of anti-tumor necrosis factor (anti-TNF) medications too early in rheumatoid arthritis (RA) patients who are set to undergo surgery, researchers at the Hospital for Special Surgery (HSS) in New York City have found.

The US Food and Drug Administration has accepted for review a New Drug Application for tofacitinib from Pfizer Inc.